$25.93
4.03% yesterday
Nasdaq, Nov 07, 10:00 pm CET

BioLife Solutions, Inc. Stock price

$25.93
-0.37 1.41% 1M
+4.59 21.51% 6M
-0.03 0.12% YTD
-0.21 0.80% 1Y
+6.75 35.19% 3Y
-6.17 19.22% 5Y
+23.61 1,017.67% 10Y
+24.67 1,957.94% 20Y
Nasdaq, Closing price Fri, Nov 07 2025
-1.09 4.03%

Key metrics

Basic
Market capitalization
$1.3b
Enterprise Value
$1.2b
Net debt
positive
Cash
$81.8m
Shares outstanding
47.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
14.2 | 12.5
EV/Sales
13.4 | 11.8
EV/FCF
3,596.1
P/B
3.7
Financial Health
Equity Ratio
87.3%
Return on Equity
-5.8%
ROCE
-0.7%
ROIC
-0.8%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$91.3m | $103.4m
EBITDA
$-190.0k | $24.3m
EBIT
$-2.5m | $-20.1m
Net Income
$-5.5m | $-17.6m
Free Cash Flow
$340.0k
Growth (TTM | estimate)
Revenue
-24.6% | 25.7%
EBITDA
99.4% | 653.7%
EBIT
92.5% | -181.4%
Net Income
92.5% | 12.9%
Free Cash Flow
104.4%
Margin (TTM | estimate)
Gross
66.3%
EBITDA
-0.2% | 23.5%
EBIT
-2.8%
Net
-6.1% | -17.0%
Free Cash Flow
0.4%
More
EPS
$-0.1
FCF per Share
$0.0
Short interest
10.0%
Employees
159
Rev per Employee
$520.0k
Show more

Is BioLife Solutions, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,024 stocks worldwide.

BioLife Solutions, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a BioLife Solutions, Inc. forecast:

15x Buy
94%
1x Hold
6%

Analyst Opinions

16 Analysts have issued a BioLife Solutions, Inc. forecast:

Buy
94%
Hold
6%

Financial data from BioLife Solutions, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
91 91
25% 25%
100%
- Direct Costs 31 31
57% 57%
34%
61 61
21% 21%
66%
- Selling and Administrative Expenses 50 50
26% 26%
54%
- Research and Development Expense 8.06 8.06
45% 45%
9%
-0.19 -0.19
99% 99%
0%
- Depreciation and Amortization 2.32 2.32
43% 43%
3%
EBIT (Operating Income) EBIT -2.51 -2.51
92% 92%
-3%
Net Profit -5.53 -5.53
92% 92%
-6%

In millions USD.

Don't miss a Thing! We will send you all news about BioLife Solutions, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

BioLife Solutions, Inc. Stock News

Neutral
Seeking Alpha
one day ago
BioLife Solutions, Inc. ( BLFS ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Troy Wichterman - Chief Financial Officer Roderick de Greef - CEO & Chairman Conference Call Participants Paul Knight - KeyBanc Capital Markets Inc., Research Division Matthew Stanton - Jefferies LLC, Research Division Steven Etoch - Stephens Inc., Research Division Brendan Smith - TD Cowen,...
Neutral
PRNewsWire
one day ago
Cell Processing revenue of $25.4 million, up 33% over Q3 2024 GAAP gross margin of 62%  and non-GAAP adjusted gross margin of 64% GAAP net income of $0.6 million and non-GAAP adjusted EBITDA of $7.8 million or 28% of revenue Raises 2025 full-year Cell Processing revenue guidance to $93.0 million - $94.0 million; Full-year total revenue guidance to $95.0 - $96.0 million, adjusted for the recent ...
Neutral
PRNewsWire
15 days ago
BOTHELL, Wash. , Oct. 23, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the Company's third quarter 2025 financial results will be released after market close on Thursday, November 6, 2025.
More BioLife Solutions, Inc. News

Company Profile

BioLife Solutions, Inc. engages in the development, manufacture, and marketing of biopreservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1998 and it is headquartered in Bothell, WA.

Head office United States
CEO Roderick Greef
Employees 159
Founded 1987
Website www.biolifesolutions.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today